AbbVie·Healthcare / Pharmaceuticals·North Chicago, United States·Founded 2013·Last verified 31 May 2026
48
out of 100
Making progressPending ReviewMixed evidence· 11 src

AbbVie has achieved meaningful absolute emissions reductions and maintains science-aligned near-term climate targets, but obscures its full supply chain footprint and lacks net-zero validation. Membership in climate-oppositional trade associations without alignment review, combined with $7.57B in regulatory penalties since 2000, signals weak governance despite robust operational disclosures.

The calculation

Every score shows its working.

Same formula for every company. No curve. No private weighting.

SINK = (0.3 × Base + 0.7 × Performance) × Scale
Industry base impact
Healthcare / Pharmaceuticals sector ceiling.
45 / 100
Performance score
Sum of the 10 rubric questions, scored 0–10 each.
53 / 100
Raw score
Weighted average before scale penalty.
(0.3 × 45) + (0.7 × 53) = 50.6
Scale penalty
Multiplier based on absolute emissions volume — physics-first.
× 0.95
Final score
Rounded. Making progress.
48 / 100
The ten questions

Where AbbVie is strong, and where it isn't.

Strongest on Carbon Footprint — Operations and Targets & Commitments (7/10, 7/10). Weakest on Nature & Biodiversity Impact and Controversies & Red Flags (3/10, 4/10).

Where the evidence comes from

Every document used, listed.

11 sources used in this assessment. All publicly available. Each row shows which rubric questions it informed.

[1]Third-party verified
DitchCarbon – AbbVie Organization Profile
Ongoing
Q1
View →
[2]Self-reported
AbbVie ESG Assurance Statements
2024
Q1Q9
View →
[3]Self-reported
AbbVie Environmental Sustainability
Ongoing
Q2Q4Q8
View →
[4]Self-reported
AbbVie 2024 CDP Climate Response
2024
Q2Q3Q5
View →
[5]Self-reported
AbbVie Contract Manufacturing 2024 ESG Action Report Review
2024
Q3Q6Q7
View →
[6]Third-party verified
Tracenable – AbbVie Climate Targets
Unknown
Q3
View →
[7]Third-party verified
The Sustainable Innovation – AbbVie Sustainability
Unknown
Q4
View →
[8]Third-party verified
World Benchmarking Alliance – Nature Benchmark: AbbVie
Unknown
Q5Q6Q7Q9
View →
[9]Public record
Good Jobs First Violation Tracker – AbbVie
Ongoing
Q10
View →
[10]Third-party verified
InfluenceMap – AbbVie Climate Change Policy Engagement
Unknown
Q10
View →
[11]Third-party verified
Net0 Tracker – AbbVie Inc.
Ongoing
Q8
View →

If you believe a source has been misread or a newer version exists, submit a challenge.

AbbVie in context

Where AbbVie sits among healthcare / pharmaceuticals peers.

Among the 11 major healthcare / pharmaceuticals brands we've scored, AbbVie is tied =6th of 11, with 1 other.

=6/11
AbbVie's rank
46
Industry average
39
Industry low
52
Industry high
How this score has moved

AbbVie's score over time.

today

Score history begins 4 April 2026.

As AbbVie's score updates, the trajectory will appear here.

We're backfilling historical scores for FTSE 100 and S&P 100 companies over the coming weeks.

What's being contested

This score is not currently being contested.

Every challenge is published. We'd rather be corrected than wrong — that's the whole point.

No challenges submitted yet. If you have evidence that contradicts this score, you can challenge any question above — cite a public source and we'll review it.

About AbbVie

AbbVie is a US-based pharmaceutical company founded in 2013 through separation from Abbott Laboratories, headquartered in North Chicago. With $58B in FY2022 revenue, it develops treatments across immunology, oncology, virology, and neuroscience. AbbVie operates a global manufacturing and R&D footprint with complex supply chains typical of large-scale pharma.

Founded
2013
Headquarters
North Chicago, United States
Employees
~55,000
Annual revenue
$58.1B (FY2022)
Company website ↗
Track AbbVie

We'll let you know when the score moves.

Email alerts when a rubric question is verified, a challenge is resolved, or the overall score changes.

THE SUNDAY RUNDOWN

Which companies moved this week, and why.

One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.

No spam. Unsubscribe in one click.

HOW SINK STAYS INDEPENDENT

Readers and institutions support our work. Companies can pay to submit evidence we couldn't find. Neither type of payment changes a score.